Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update

J Oncol Pract. 2015 May;11(3):e442-4. doi: 10.1200/JOP.2015.004473. Epub 2015 Apr 14.

Authors

Gary H Lyman¹, Kari Bohlke¹, Anna Falanga¹; American Society of Clinical Oncology

Affiliation

¹ Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; American Society of Clinical Oncology, Alexandria, VA; and Hospital Papa Giovanni XXIII, Bergamo, Italy.

PMID: 25873061
DOI: 10.1200/JOP.2015.004473

No abstract available

Publication types

Practice Guideline
Review

MeSH terms

Anticoagulants / administration & dosage*
Anticoagulants / adverse effects
Fibrinolytic Agents / administration & dosage*
Fibrinolytic Agents / adverse effects
Humans
Neoplasms / blood
Neoplasms / complications
Neoplasms / drug therapy*
Patient Selection
Risk Assessment
Risk Factors
Treatment Outcome
Venous Thromboembolism / blood
Venous Thromboembolism / drug therapy*
Venous Thromboembolism / etiology
Venous Thromboembolism / prevention & control*

Substances

Anticoagulants
Fibrinolytic Agents